NEOGENOMICS INC

NASDAQ: NEO (NeoGenomics, Inc.)

Kemas kini terakhir: 31 May, 11:48PM

7.28

-0.09 (-1.22%)

Penutupan Terdahulu 7.37
Buka 7.36
Jumlah Dagangan 1,266,044
Purata Dagangan (3B) 2,080,549
Modal Pasaran 936,899,648
Harga / Jualan (P/S) 1.32
Harga / Buku (P/B) 1.01
Julat 52 Minggu
6.08 (-16%) — 19.11 (162%)
Tarikh Pendapatan 28 Jul 2025
Margin Keuntungan -11.54%
Margin Operasi (TTM) -16.56%
EPS Cair (TTM) -0.610
Pertumbuhan Hasil Suku Tahunan (YOY) 7.50%
Jumlah Hutang/Ekuiti (D/E MRQ) 68.08%
Nisbah Semasa (MRQ) 2.05
Aliran Tunai Operasi (OCF TTM) 7.61 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -2.21 M
Pulangan Atas Aset (ROA TTM) -2.75%
Pulangan Atas Ekuiti (ROE TTM) -8.56%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Diagnostics & Research (US) Menurun Menurun
Diagnostics & Research (Global) Menurun Menurun
Stok NeoGenomics, Inc. Menurun Menurun

AISkor Stockmoo

0.9
Konsensus Penganalisis 1.0
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal 2.5
Osilator Teknikal -0.5
Purata 0.88

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
NEO 937 M - - 1.01
EXAS 10 B - - 4.18
MEDP 9 B - 24.51 15.20
GH 6 B - - 55.67
RDNT 4 B - - 4.61
VCYT 2 B - 102.58 1.73

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Sektor Healthcare
Industri Diagnostics & Research
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 1.19%
% Dimiliki oleh Institusi 100.73%
69.9569.9553.6053.6037.2537.2520.9020.904.554.55Harga Sasaran MedianQ3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
6.08 (-16%) — 19.11 (162%)
Julat Harga Sasaran
8.50 (16%) — 12.00 (64%)
Tinggi 12.00 (Piper Sandler, 64.84%) Beli
Median 10.00 (37.36%)
Rendah 8.50 (Needham, 16.76%) Beli
Purata 9.90 (35.99%)
Jumlah 3 Beli, 2 Pegang
Harga Purata @ Panggilan 6.87
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Piper Sandler 06 May 2025 12.00 (64.84%) Beli 7.69
Morgan Stanley 01 May 2025 10.00 (37.36%) Pegang 7.26
Goldman Sachs 30 Apr 2025 10.00 (37.36%) Beli 6.40
17 Apr 2025 15.00 (106.04%) Beli 9.55
Leerink Partners 30 Apr 2025 9.00 (23.63%) Pegang 6.40
Needham 29 Apr 2025 8.50 (16.76%) Beli 6.58

Tiada data dalam julat masa ini.

8.198.197.707.707.217.216.726.726.236.23Jun 11Jun 11Jun 12Jun 12Jun 13Jun 13Jun 16Jun 16Jun 17Jun 17Jun 18Jun 18Jun 20Jun 20Jun 23Jun 23

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.1000.100-0.000-0.000-0.100-0.100-0.200-0.200-0.300-0.300MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda